139 related articles for article (PubMed ID: 11369372)
1. Fas expression and apoptosis in rats with experimental autoimmune uveoretinitis.
Abe T; Nakajima A; Satoh N; Sakuragi S
Jpn J Ophthalmol; 2001; 45(3):240-6. PubMed ID: 11369372
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of apoptotic cells in experimental autoimmune uveoretinitis.
Sueda J; Hikita N; Mochizuki M; Jimi A; Kojiro M
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):799-804. PubMed ID: 10711696
[TBL] [Abstract][Full Text] [Related]
3. [Effects of leflunomide on experimental autoimmune uveitis in Lewis rats].
Fang C; Zhou D; Zhan S; He Y; Lin Z; Huang C; Li J
Zhonghua Yan Ke Za Zhi; 2015 Oct; 51(10):754-61. PubMed ID: 26693771
[TBL] [Abstract][Full Text] [Related]
4. Intraocular cytokine quantification of experimental autoimmune uveoretinitis in rats.
Okada AA; Sakai J; Usui M; Mizuguchi J
Ocul Immunol Inflamm; 1998 Jun; 6(2):111-20. PubMed ID: 9689641
[TBL] [Abstract][Full Text] [Related]
5. High mobility group box protein-1 in experimental autoimmune uveoretinitis.
Watanabe T; Keino H; Sato Y; Kudo A; Kawakami H; Okada AA
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2283-90. PubMed ID: 19151394
[TBL] [Abstract][Full Text] [Related]
6. Contribution of CD4+CD25+ T cells to the regression phase of experimental autoimmune uveoretinitis.
Sun M; Yang P; Du L; Zhou H; Ren X; Kijlstra A
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):383-9. PubMed ID: 19696173
[TBL] [Abstract][Full Text] [Related]
7. CCR5-deficient mice develop experimental autoimmune uveoretinitis in the context of a deviant effector response.
Takeuchi A; Usui Y; Takeuchi M; Hattori T; Kezuka T; Suzuki J; Okunuki Y; Iwasaki T; Haino M; Matsushima K; Usui M
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3753-60. PubMed ID: 16186359
[TBL] [Abstract][Full Text] [Related]
8. Effect of sex hormones on experimental autoimmune uveoretinitis (EAU).
Buggage RR; Matteson DM; Shen DF; Sun B; Tuaillon N; Chan CC
Immunol Invest; 2003 Nov; 32(4):259-73. PubMed ID: 14603994
[TBL] [Abstract][Full Text] [Related]
9. IL-18 not required for IRBP peptide-induced EAU: studies in gene-deficient mice.
Jiang HR; Wei X; Niedbala W; Lumsden L; Liew FY; Forrester JV
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):177-82. PubMed ID: 11133864
[TBL] [Abstract][Full Text] [Related]
10. Fas/Fas ligand-associated apoptosis in experimental autoimmune uveoretinitis in rodents: role of proinflammatory corticotropin-releasing hormone.
Poulaki V; Mitsiades N; Mastorakos G; Caspi RR; Chrousos GP; Bouzas E
Exp Eye Res; 2001 Jun; 72(6):623-9. PubMed ID: 11384150
[TBL] [Abstract][Full Text] [Related]
11. Prevention of experimental autoimmune uveoretinitis by vasoactive intestinal peptide.
Keino H; Kezuka T; Takeuchi M; Yamakawa N; Hattori T; Usui M
Arch Ophthalmol; 2004 Aug; 122(8):1179-84. PubMed ID: 15302659
[TBL] [Abstract][Full Text] [Related]
12. Effects of monoclonal antibodies directed at cell surface molecules on murine experimental autoimmune uveoretinitis.
Ando K; Fujino Y; Mochizuki M
Graefes Arch Clin Exp Ophthalmol; 1999 Oct; 237(10):848-54. PubMed ID: 10502060
[TBL] [Abstract][Full Text] [Related]
13. Oral administration of interferon-beta suppresses experimental autoimmune uveoretinitis.
Suzuki J; Sakai J; Okada AA; Takada E; Usui M; Mizuguchi J
Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):314-21. PubMed ID: 11981647
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs in retina during development of experimental autoimmune uveoretinitis in rats.
Watanabe T; Keino H; Kudo A; Sato Y; Okada AA
Br J Ophthalmol; 2016 Mar; 100(3):425-31. PubMed ID: 26541434
[TBL] [Abstract][Full Text] [Related]
15. Effects of experimental ocular inflammation on ocular immune privilege.
Ohta K; Wiggert B; Taylor AW; Streilein JW
Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2010-8. PubMed ID: 10440255
[TBL] [Abstract][Full Text] [Related]
16. Suppression of actively induced experimental autoimmune uveoretinitis by CD4+ T cells.
Uchio E; Kijima M; Ishioka M; Tanaka S; Ohno S
Graefes Arch Clin Exp Ophthalmol; 1997 Feb; 235(2):97-102. PubMed ID: 9147958
[TBL] [Abstract][Full Text] [Related]
17. Abrogation of Rbpj attenuates experimental autoimmune uveoretinitis by inhibiting IL-22-producing CD4+ T cells.
Bhuyan ZA; Asanoma M; Iwata A; Ishifune C; Maekawa Y; Shimada M; Yasutomo K
PLoS One; 2014; 9(2):e89266. PubMed ID: 24586644
[TBL] [Abstract][Full Text] [Related]
18. Inducible co-stimulator (ICOS) is upregulated in experimental autoimmune uveoretinitis.
Xing L; Yang P; Wu C; Jin H; Chen X; Gao Y; Li B; Huang X; Zhou H
Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1650-8. PubMed ID: 16601981
[TBL] [Abstract][Full Text] [Related]
19. Activation of the Notch signaling pathway disturbs the CD4
Yin X; Liu B; Wei H; Wu S; Guo L; Xu F; Liu T; Bi H; Guo D
Inflamm Res; 2019 Sep; 68(9):761-774. PubMed ID: 31209505
[TBL] [Abstract][Full Text] [Related]
20. Suppression of experimental autoimmune uveoretinitis by Anti-IL-17 antibody.
Zhang R; Qian J; Guo J; Yuan YF; Xue K
Curr Eye Res; 2009 Apr; 34(4):297-303. PubMed ID: 19373578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
